Confluence Life Sciences
A company dedicated to drug designs to develop kinase inhibitors for healthcare of human and animals
2
Funding Rounds
$4.1m
Money raised
Overview
A company dedicated to drug designs to develop kinase inhibitors for healthcare of human and animals
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Confluence Life Sciences has raised a total of $4.08m in funding over 2 rounds.
Key Insights:
- Confluence Life Sciences Series A round: $4m
- Confluence Life Sciences seed round: $75k
Confluence Life Sciences Series A round
$4m
Confluence Life Sciences seed round
$75k
Industries
Confluence Life Sciences is active in the following industries: